Why Aphria Inc (TSX:APHA) Stock Rose 17% in August

Despite what was a pretty rough month for cannabis stocks, shares in Aphria Inc (TSX:APHA(NYSE:APHA), rose 17% in August. Find out what led to the stocks outperformance in this rapidly growing and exciting market.

Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

Despite what’s been for the most part a rough patch for cannabis stocks, shares in Aphria Inc (TSX:APHA)(NYSE:APHA), Canada’s fourth largest licensed pot producer, rose 17% in August.

So what exactly led to APHA’s outperformance last month?

Let’s take a closer look and find out.

Aphria reported its fourth quarter and fiscal year-end earnings on August 1, and for the most part, the results were fairly encouraging.

Backed by strong growth in adult use, Aphria delivered impressive year-over-year numbers including revenues up 969% and gross profits that nearly doubled.

Growth was encouraging against its most recent third quarter results as well, including 75% net revenue growth and revenues for adult-use cannabis us 158% from the prior quarter.

Once again, the company continues to demonstrate that it can deliver results on a profitable basis as well, reporting net income of $15.8 million in the fourth quarter and adjusted EBITDA of $1.9 million for the quarter.

Those results compare favourably to the net loss of $108 million it had reported in the third quarter — and better than the $5 million in net losses reported in the fourth quarter one year ago.

Meanwhile, Aphria also closed a convertible note offering during the fourth quarter for proceeds of over US$335 million at a rate of 5.25% per year, and now has over $571 million of cash sitting on its books, including marketable investments.

That should set it up well to go after not only an expanding Canadian market, but also a rapidly growing international market for cannabis.

Also, while revenues per gram of cannabis sold did decline in the quarter, the company continues to go after new and untapped markets for the drug, including the announcement of a new CBD-based nutraceutical product line for the German market earlier this year.

With more than 200,000 plants already under cultivation for the current grow season, including the new expanded area of its Aphria One facility, management feels as though its now on track for annual production capacity of as much as 255,000 kilograms of the drug once all is said and done, including having received licenses for all of its facilities.

Foolish bottom line

In light of the fact that Aphria sold just 5,774 kilograms of cannabis during the fourth quarter those forecasted production estimates suggest that there’s still a long road ahead of this company before it truly gets to where it wants to go.

Yet it could prove to be a handsomely rewarding and exciting road for investors — provided management can trim some of its existing operating costs and return itself to the form that it was in when it became the first licensed pot producer to record a quarterly net profit.

Investors interested in the cannabis space will want to continue to watch this exciting company, which, despite a strong showing in August, still trades toward the bottom end of its trailing twelve-month price range.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jason Phillips has no position in any of the stocks mentioned.

More on Cannabis Stocks

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »